Skip to Content

'
Bouthaina S. Dabaja, M.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Clinical Section Chief of Lymphoma, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1990 Lebanese University-Faculty of Medicine, Beirut, Lebanon, MD, Medicine

Postgraduate Training

2003 Clinical Fellowship, Stereotactic 3D Conformal Fellowship, The University of Texas MD Anderson Cancer Center (Non-Accredited Participation in Program), Houston, TX
1999-2003 Clinical Residency, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
1997-1999 Clinical Fellowship, Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
1993-1996 Clinical Fellowship, Hematology, American University of Beirut-Faculty of Medicine, Beirut, Lebanon
1990-1993 Clinical Residency, Internal Medicine, American University of Beirut-Faculty of Medicine, Beirut, Lebanon

Board Certifications

6/2003 American Board of Radiology, Recertification Date: 3/2015

Experience/Service

Academic Appointments

Assistant Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006-2010
Assistant Professor, Department of Radiation Oncology, Division of Radiation Oncology, American University of Beirut-Medical Center, Beirut, Lebanon, 2003-2006

Other Appointments/Responsibilities

Panel Expert, American College of Radiology Appropriateness Criteria: Radiation Oncology, Lymphoma Panel, Reston, VA, 2011-present
Panel Expert, International Lymphoma Radiation Oncology Group Steering Committee, Copenhagen, Denmark, 2011-present
Panel Expert, Radiation Oncology- Hodgkins Disease Working Group Panel, American College of Radiology, Reston, VA, 2011-2012
Oral Board Examiner, American Board of Radiology, Louisville, KY, 2010-present
Panel Member, National Comprehensive Cancer Network Hodgkin's Lymphoma Panel, Washington, DC, 2007-present

Institutional Committee Activities

Senate Representative, Faculty Senate Committee, 2013-2016
Member, Credentials Committee of the Medical Staff, 2011-2014
Member, T-Cell Lymphoma Group, 2009-present
Member, Hodgkin's Lymphoma Group, 2008-present
Member, The University of Texas MD Anderson Cancer Center- American University of Beirut Faculty of Medicine Steering Committee, 2007-present
Member, Clinical Effectiveness Committee, 2007-2013
Member, Lymphoma Steering Committee, 2006-present

Honors and Awards

2016-present Robert M. Chamberlain Mentor Award, The University of Texas MD Anderson Cancer Center
2015 Educator of the Month, The University of Texas MD Anderson Cancer Center
2015 Finalist in Provost Distinguished Mentoring Award Nominee, The University of Texas MD Anderson Cancer Center
2015 James D. Cox Mentoring Award, The University of Texas MD Anderson Cancer Center
2008-2009 Teacher of the Year Award, Association of Residents in Radiation Oncology
2003 Janice Davis Singletary Award
2003 Oncology Fellows Connect Program Nominee
2002 Honorary Merit-Radiation Research Award
2001 Research Education Award, The University of Texas MD Anderson Cancer Center

Professional Memberships

American Board of Radiology, Louisville, KY
Oral Exam Writer, 2014-present
Written Exam Writer, 2014-present
Radiation Oncology Lymphoma Committee Member, 2010-present
American College of Radiology
Member, 6/2000-present
American Society of Clinical Oncology
Member, 6/1999-present
American Society of Hematology
Member, 6/2000-present
American Society of Radiation Oncology
Chair, for Lymphoma/Hematologic Malignancies Abstract Committee, 10/2014-10/2016
Best of ASTRO Scientific Committee Member, 2014-present
Best of ASTRO Steering Committee Member, 2014-present
Annual Meeting Scientific Committee Member, 2013-present
Member, 6/2001-present
International Extranodal Lymphoma Study Group
Member, 6/2007-present
International Lymphoma Radiation Oncology Group
Member, 10/2010-present
Radiological Society of North America
Member, 2015-present
Southwest Oncology Group
Member, 2012-present
United States Cutaneous Lymphoma Consortium
Member, 12/2009-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Roberts K, Younes A, Hodgson D, Advani R, Dabaja BS, Dhakal S, Flowers C, Ha C, Hoppe B, Mendenhall N, Metzger M, Plastaras J, Shapiro R, Smith S, Terezakis S, Winkfield K, Constine L. ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II. American Journal of Clinical Oncology. In Press.
2. Ramya Chockalingam, Bouthaina Dabaja, M.D., Madeleine Duvic, M.D. Indolent CD8-positive Lymphoid Proliferation of the Foot: a case report. Clinical Lymphoma, Myeloma & Leukemia. In Press.
3. Liang FW, Chan W, Swartz M, Dabaja B, Etzel C. Joint modeling of a mixture time-to-event variable with its discrete and continuous mixture covariates. Stat Med. In Press.
4. L. Million, E. J. Yi, F. Wu, R. Von Eyben, B. A. Campbell, <b>B. Dabaja</b>, R.W. Tsang, A. Ng, L.D. Wilson, U. Ricardi, Y. Kirova, R.T. Hoppe. Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma (pcALCL): An International Lymphoma Radiation Oncology Group (ILROG) Multi-institutional Experience. International Journal of Radiation Oncology*Biology*Physics. In Press. PMID: Ms. No. ROB-D-16-00022R1.
5. Chelsea C. Pinnix MD, PhD, Eleanor M. Osborne MD, Dai Chichara MD, Peter Lai BS, Mildred M. Ramirez MD, Yasuhiro Oki MD, Frederick B. Hagemeister MD, Alma M. Rodriguez MD, Felipe Samaniego MD, Nathan Fowler MD, Jorge E. Romaguera MD, Francesco Turturro MD, Luis Fayad MD, Jason R. Westin MD, Loretta Nastoupil MD, Chan Y. Cheah MD, Bouthaina S. Dabaja MD, Sarah Milgrom MD, Grace L. Smith MD, PhD, Patricia Horace BS, Shouhao Zhou BS, Andrea Milbourne MD, Sue A. Rimes BS, Christine F. Wogan BS, Leslie Ballas MD, Michelle A. Fanale MD. Successful Maternal and fetal outcomes after therapy for Hodgkin or non-Hodgkin lymphoma diagnosed during pregnancy. JAMA Oncology. In Press.
6. Jillian R. Gunther, MD, PhD, Michelle Fanale, MD, Jay P. Reddy, MD, PhD, Mani Akhtari, MD, Grace L. Smith, MD, PhD, Chelsea Pinnix, MD, PhD, Sarah A. Milgrom, MD, Zeinab Abou Yehia, MD, Eleanor M. Osborne, MD, M. Osama Mawlawi, MD, Pamela K. Allen, PhD, and Bouthaina S. Dabaja MD. Treatment of early unfavorable Hodgkin’s lymphoma patients: A comparison of the efficacy and toxicity of 4 vs. 6 cycles of ABVD chemotherapy with radiation. In Press.
7. Dabaja BS, Mikhaeel NG. In the Battle Between Protons and Photons for Hematologic Malignancies, the Patient Must Win. Int J Radiat Oncol Biol Phys 95(1):43-5, 5/2016. PMID: 27084623.
8. Ng AK, Dabaja BS, Hoppe RT, Illidge T, Yahalom J. Re-Examining the Role of Radiation Therapy for Diffuse Large B-Cell Lymphoma in the Modern Era. J Clin Oncol 34(13):1443-7, 5/2016. e-Pub 2/2016. PMID: 26903576.
9. Milgrom SA, Cheah CY, Pinnix CC, Smith GL, Dabaja BS, Horace P, Chevez-Barrios P, Fowler NH, Gombos DS. Acute and late toxicity of bilateral orbital irradiation in the management of primary intraocular lymphoma. Leuk Lymphoma. e-Pub 4/2016. PMID: 27075636.
10. Cheah CY, Milgrom S, Chihara D, Gombos DS, Pinnix CC, Dabaja BS, Fowler NH. Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma. Neuro Oncol 18(4):575-81, 4/2016. e-Pub 10/2015. PMCID: PMC4799685.
11. Kim MM, Dabaja BS, Medeiros J, Kim S, Allen P, Chevez-Barrios P, Gombos DS, Fowler N. Survival outcomes of primary intraocular lymphoma: a single-institution experience. Am J Clin Oncol 39(2):109-13, 4/2016. e-Pub 1/2014. PMID: 24390272.
12. Pinnix CC, Shah JJ, Chuang H, Costelloe CM, Medeiros LJ, Wogan CF, Reed V, Smith GL, Milgrom S, Patel K, Huo J, Turturro F, Romaguera J, Fayad L, Oki Y, Fanale MA, Westin J, Nastoupil L, Hagemeister FB, Rodriguez A, Qazilbash M, Shah N, Bashir Q, Ahmed S, Nieto Y, Hosing C, Rohren E, Dabaja B. Doxorubicin-based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review. Clin Lymphoma Myeloma Leuk 16(3):122-8, 3/2016. e-Pub 12/2015. PMID: 26795083.
13. Talpur R, Sui D, Gangar P, Dabaja BS, Duvic M. Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides. Clin Lymphoma Myeloma Leuk 16(1):49-56, 1/2016. e-Pub 12/2015. PMID: 26702474.
14. Akhtari M, Reddy JP, Pinnix CC, Allen PK, Osborne EM, Gunther JR, Milgrom SA, Smith GL, Wogan CF, Fowler N, Rodriguez MA, Dabaja B. Primary Cutaneous B-cell Lymphoma (Non-Leg Type) Has Excellent Outcomes Even After Very Low Dose Radiation as Single-Modality Therapy. Leuk Lymphoma 57(1):1-13, 2016. e-Pub 5/2015. PMID: 25860237.
15. Dabaja BS, Advani R, Hodgson DC, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma. Am J Clin Oncol 38(6):610-20, 12/2015. PMID: 26583344.
16. Hosing C, Bassett R, Dabaja B, Talpur R, Alousi A, Ciurea S, Popat U, Qazilbash M, Shpall EJ, Oki Y, Nieto Y, Pinnix C, Fanale M, Maadani F, Donato M, Champlin R, Duvic M. Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution. Ann Oncol 26(12):2490-5, 12/2015. e-Pub 9/2015. PMCID: PMC4855245.
17. Xu-Monette ZY, Dabaja BS, Wang X, Tu M, Manyam GC, Tzankov A, Xia Y, Zhang L, Sun R, Visco C, Dybkaer K, Yin L, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Møller MB, Parsons BM, Zhao X, Winter JN, Piris MA, McDonnell TJ, Miranda RN, Li Y, Medeiros LJ, Young KH. Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol 28(12):1555-73, 12/2015. e-Pub 11/2015. PMID: 26541272.
18. Brown DN, Wieser I, Wang C, Dabaja BS, Duvic M. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature. J Am Acad Dermatol 73(6):976-86, 12/2015. e-Pub 10/2015. PMID: 26476898.
19. Reddy JP, Akhtari M, Smith GL, Pinnix C, Osborne EM, Gunther JR, Allen PK, Yehia ZA, Fanale M, Rodriguez MA, Fowler N, Milgrom SA, Wogan CF, Dabaja BS. Outcomes after Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma with Bulky Disease. Clin Lymphoma Myeloma Leuk 15(11):664-670.e2, 11/2015. e-Pub 8/2015. PMID: 26321471.
20. Nieto Y, Valdez BC, Thall PF, Ahmed S, Jones RB, Hosing C, Popat U, Shpall EJ, Qazilbash M, Gulbis A, Anderlini P, Alousi A, Shah N, Bashir Q, Liu Y, Oki Y, Hagemeister F, Fanale M, Dabaja B, Pinnix C, Champlin R, Andersson BS. Vorinostat Combined with High-Dose Gemcitabine, Busulfan and Melphalan with Autologous Stem-Cell Transplantation in Patients with Refractory Lymphomas. Biol Blood Marrow Transplant S1083-8791(15):405, 11/2015. e-Pub 6/2015. PMCID: PMC4781754.
21. Wang C, Reusser N, Shelton M, Reed J, Doan H, Torres-Cabala CA, Dabaja B, Duvic M. An unusual case of cytotoxic peripheral T-cell lymphoma. JAAD Case Rep 1(5):257-60, 9/2015. e-Pub 7/2015. PMCID: PMC4809218.
22. Zhou R, Yang J, Pan T, Milgrom S, Pinnix C, Shi A, Yang J, Liu Y, Nguyen Q, Gomez D, Dabaja B, Balter P, Court L, Liao Z. SU-E-J-129: Atlas Development for Cardiac Automatic Contouring Using Multi-Atlas Segmentation. Med Phys 42(6):3294, 6/2015.
23. Tao R, Allen PK, Rodriguez A, Shihadeh F, Pinnix CC, Arzu I, Reed VK, Oki Y, Westin JR, Fayad LE, Medeiros LJ, Dabaja B. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma. Int J Radiat Oncol Biol Phys 92(1):122-9, 5/2015. e-Pub 3/2015. PMID: 25754633.
24. Polansky M, Talpur R, Daulat S, Hosing C, Dabaja B, Duvic M. Long-term complete responses to combination therapies and allogeneic stem cell transplants in patients with Sézary syndrome. Clin Lymphoma Myeloma Leuk 15(5):83-93, 5/2015. e-Pub 10/2014. PMID: 25458083.
25. Specht L, Dabaja B, Illidge T, Wilson LD, Hoppe RT, International Lymphoma Radiation Oncology Group. Modern radiation therapy for primary cutaneous lymphomas - field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys 92(1):32-39, 5/2015. PMID: 25863751.
26. Pinnix CC, Smith GL, Milgrom S, Osborne EM, Reddy JP, Akhtari M, Reed V, Arzu I, Allen PK, Wogan CF, Fanale MA, Oki Y, Turturro F, Romaguera J, Fayad L, Fowler N, Westin J, Nastoupil L, Hagemeister FB, Rodriguez MA, Ahmed S, Nieto Y, Dabaja B. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for hodgkin and non-hodgkin lymphoma. Int J Radiat Oncol Biol Phys 92(1):175-82, 5/2015. PMCID: PMC4418193.
27. Maraldo MV, Dabaja BS, Filippi AR, Illidge T, Tsang R, Ricardi U, Petersen PM, Schut DA, Garcia J, Headley J, Parent A, Guibord B, Ragona R, Specht L. Radiotherapy planning for early stage Hodgkin lymphoma: experiences of the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 92(1):144-52, 5/2015. e-Pub 2/2015. PMID: 25670544.
28. Pinnix CC, Dabaja B, Ahmed MA, Chuang HH, Costelloe C, Wogan CF, Reed V, Romaguera JE, Neelapu S, Oki Y, Rodriguez MA, Fayad L, Hagemeister FB, Nastoupil L, Turturro F, Fowler N, Fanale MA, Nieto Y, Khouri IF, Ahmed S, Medeiros LJ, Davis RE, Westin J. Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by (18)fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys 92(1):113-21, 5/2015. PMCID: PMC4418191.
29. Dabaja BS, Vanderplas AM, Crosby-Thompson AL, Abel GA, Czuczman MS, Friedberg JW, Gordon LI, Kaminski M, Niland J, Millenson M, Nademanee AP, Zelenetz A, LaCasce AS, Rodriguez MA. Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network Lymphoma Outcomes Project. Cancer 121(7):1032-1039, 4/2015. e-Pub 12/2014. PMID: 25492236.
30. Hoppe RT, Harrison C, Tavallaee M, Bashey S, Sundram U, Li S, Million L, Dabaja B, Gangar P, Duvic M, Kim YH. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from three phase II clinical trials. J Am Acad Dermatol 72(2):286-92, 2/2015. e-Pub 12/2014. PMID: 25476993.
31. Kenneth B. Roberts, MD; Anas Younes, MD; David C. Hodgson, MD; Ranjana Advani, MD; Bouthaina S. Dabaja, MD; Sughosh Dhakal, MD; Christopher R. Flowers, MD, MS; Chul S. Ha, MD; Bradford S. Hoppe, MD, MPH; Nancy P. Mendenhall, MD; Monika L. Metzger, MD; John P. Plastaras, MD, PhD; Ronald Shapiro, MD; Sonali M. Smith, MD; Stephanie A. Terezakis, MD; Karen M. Winkfield, MD, PhD; Louis S. Constine, MD. Hodgkin Lymphoma-Unfavorable Clinical Stage I and II. American College of Radiology, 2015.
32. Youssef B, Shank J, Reddy JP, Pinnix CC, Farha G, Akhtari M, Allen PK, Fanale MA, Garcia JA, Horace PH, Milgrom S, Smith GL, Nieto Y, Arzu I, Wang H, Fowler N, Rodriguez MA, Dabaja B. Incidence and predictors of Lhermitte's sign among patients receiving mediastinal radiation for lymphoma. Radiat Oncol 10(1):206, 2015. e-Pub 9/2015. PMCID: PMC4582821.
33. Walker GV, Shihadeh F, Kantarjian H, Allen P, Rondon G, Kebriaei P, O'Brien S, Kedir A, Said M, Grant JD, Thomas DA, Gidley PW, Arzu I, Pinnix C, Reed V, Dabaja BS. Comprehensive craniospinal radiation for controlling central nervous system leukemia. Int J Radiat Oncol Biol Phys 90(5):1119-1125, 12/2014. PMID: 25539370.
34. Haque W, Voong KR, Shihadeh F, Arzu I, Pinnix C, Mazloom A, Medeiros LJ, Romaguera J, Rodriguez A, Wang M, Allen P, Dabaja B. Radiation therapy is an effective modality in the treatment of mantle cell lymphoma, even in heavily pretreated patients. Clin Lymphoma Myeloma Leuk 14(6):474-479, 12/2014. e-Pub 7/2014. PMID: 25108680.
35. Ha CS, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith S, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria: follow-up of Hodgkin lymphoma. J Am Coll Radiol 11(11):1026-1033.e3, 11/2014. e-Pub 9/2014. PMID: 25278496.
36. Hamdi A, Mawad R, Bassett R, di Stasi A, Ferro R, Afrough A, Ram R, Dabaja B, Rondon G, Champlin R, Sandmaier BM, Doney K, Bar M, Kebriaei P. Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20(11):1767-1771, 11/2014. e-Pub 7/2014. PMCID: PMC4346133.
37. Oki Y, Noorani M, Lin P, Davis RE, Neelapu SS, Ma L, Ahmed M, Rodriguez MA, Hagemeister FB, Fowler N, Wang M, Fanale MA, Nastoupil L, Samaniego F, Lee HJ, Dabaja BS, Pinnix CC, Medeiros LJ, Nieto Y, Khouri I, Kwak LW, Turturro F, Romaguera JE, Fayad LE, Westin JR. Double hit lymphoma: the MD Anderson Cancer Center clinical experience. Br J Haematol 166(6):891-901, 9/2014. e-Pub 6/2014. PMID: 24943107.
38. Dabaja BS, Hess K, Shihadeh F, Podoloff DA, Medeiros LJ, Mawlawi O, Arzu I, Oki Y, Hagemeister FB, Fayad LE, Reed VK, Kedir A, Wogan CF, Rodriguez A. Positron emission tomography/computed tomography findings during therapy predict outcome in patients with diffuse large B-cell lymphoma treated with chemotherapy alone but not in those who receive consolidation radiation. Int J Radiat Oncol Biol Phys 89(2):384-391, 6/2014. e-Pub 4/2014. PMID: 24721592.
39. Illidge T, Specht L, Yahalom J, Aleman B, Berthelsen AK, Constine L, Dabaja B, Dharmarajan K, Ng A, Ricardi U, Wirth A,. Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 89(1):49-58, 5/2014. PMID: 24725689.
40. Oki Y, Chuang H, Chase B, Jessop A, Pan T, Fanale M, Dabaja B, Fowler N, Romaguera J, Fayad L, Hagemeister F, Rodriguez MA, Neelapu S, Samaniego F, Kwak L, Younes A. The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma. Br J Haematol 165(1):112-116, 4/2014. e-Pub 1/2014. PMID: 24386943.
41. Voong KR, McSpadden K, Pinnix CC, Shihadeh F, Reed V, Salehpour MR, Arzu I, Wang H, Hodgson D, Garcia J, Aristophanous M, Dabaja BS. Dosimetric advantages of a "butterfly" technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin's lymphoma. Radiat Oncol 9(1):94, 2014. e-Pub 4/2014. PMCID: PMC4013438.
42. Chi P,Pinnix C, Dabaja B, Wang C, Aristophanous M, Tung S. SU-E-T-404: Simple Field-In-Field Technique for Total Body Irradiation in Large Patients. Medical Physics 41(6):318, http://dx.doi.org/10.1118/1.4888737, 2014.
43. Aristophanous M, Chi P, Tung S, Pinnix C, Dabaja B,. SU-E-T-522: A Multi-Isocenter VMAT Technique for Cranio-Spinal Irradiation. Medical Physics 41(6):347, http://dx.doi.org/10.1118/1.4888855, 2014.
44. Dabaja BS, Phan J, Mawlawi O, Medeiros LJ, Etzel C, Liang FW, Podoloff D, Oki Y, Hagemeister FB, Chuang H, Fayad LE, Westin JR, Shihadeh F, Allen PK, Wogan CF, Rodriguez MA. Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma. Leuk Lymphoma 54(12):2631-2638, 12/2013. e-Pub 5/2013. PMCID: PMC3827734.
45. Hoppe BS, Hodgson DC, Advani R, Dabaja BS, Flowers CR, Ha CS, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria: Localized nodal indolent lymphoma. Oncology (Williston Park) 27(8):786-794, 8/2013. PMID: 24133827.
46. Wang CM, Duvic M, Dabaja BS. Acral erosive mycosis fungoides: successful treatment with localised radiotherapy. BMJ Case Rep 2013, 2013. e-Pub 4/2013. PMCID: PMC3645827.
47. Wang, H.; Tung, S.; Wang, C.; Mahajan, A.; Dabaja B, Martel, M. SU-E-T-592: Investigation of Volumetric Modulated Arc Therapy for Total Body Irradiation with Lung Blocks. Medical Physics 40(6):341, http://scitation.aip.org/content/aapm/journal/medphys/40/6/10.1118/1.4815020, 2013.
48. Pinnix CC, Reed V, Dabaja B. Gastric MALT lymphoma treated with primary radiotherapy in the setting of autoimmune disease. J Natl Compr Canc Netw 10(7):815-819, 7/2012. PMID: 22773797.
49. Batty N, Hagemeister FB, Feng L, Romaguera JE, Rodriguez MA, McLaughlin P, Samaniego F, Copeland A, Dabaja BS, Younes A. Doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy with interferon for advanced stage classic hodgkin's lymphoma: a 10-year follow-up study. Leuk Lymphoma 53(5):801-806, 5/2012. e-Pub 1/2012. PMID: 22023528.
50. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Winter JN, Yahalom J, Sundar H,. Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines. J Natl Compr Canc Netw 10(5):589-597, 5/2012. PMID: 22570290.
51. Younes A, Oki Y, McLaughlin P, Copeland AR, Goy A, Pro B, Feng L, Yuan Y, Chuang HH, Macapinlac HA, Hagemeister F, Romaguera J, Samaniego F, Fanale MA, Dabaja BS, Rodriguez MA, Dang N, Kwak LW, Neelapu SS, Fayad LE. Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma. Blood 119(18):4123-4128, 5/2012. e-Pub 2/2012. PMCID: PMC3359733.
52. Shihadeh F, Reed V, Faderl S, Medeiros LJ, Mazloom A, Hadziahmetovic M, Kantarjian H, Allen P, Ballas L, Pierce S, Dabaja B. Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease. Cancer 118(1):112-117, 1/2012. e-Pub 6/2011. PMID: 21692072.
53. Sharp H, Grosshans D, Kadia T, Dabaja BS. Cutaneous graft-versus-host disease after proton-based craniospinal irradiation for recurrent Philadelphia-positive acute lymphoblastic leukaemia. BMJ Case Rep 2012, 2012. e-Pub 7/2012. PMCID: PMC3417036.
54. Dabaja B, Wang Z, Stovall M, Baker JS, Smith SA, Khan M, Ballas L, Salehpour MR. Involved field radiation for Hodgkin's lymphoma: the actual dose to breasts in close proximity. Med Dosim 37(4):374-382, 2012. e-Pub 4/2012. PMID: 22513213.
55. Phan J, Mazloom A, Abboud M, Salehpour M, Reed V, Zreik T, Shihadeh F, Fisher C, Wogan C, Dabaja B. Consolidative radiation therapy for stage III Hodgkin lymphoma in patients who achieve complete response after ABVD chemotherapy. Am J Clin Oncol 34(5):499-505, 10/2011. e-Pub 4/2011. PMID: 21537149.
56. Reed V, Shah J, Medeiros LJ, Ha CS, Mazloom A, Weber DM, Arzu IY, Orlowski RZ, Thomas SK, Shihadeh F, Alexanian R, Dabaja BS. Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy. Cancer 117(19):4468-4474, 10/2011. e-Pub 3/2011. PMID: 21437886.
57. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Bello CM, Bierman PJ, Blum KA, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Weiss L, Winter JN, Yahalom J. Hodgkin lymphoma. J Natl Compr Canc Netw 9(9):1020-1058, 9/2011. PMID: 21917626.
58. Li J, Dabaja B, Reed V, Allen PK, Cai H, Amin MV, Garcia JA, Cox JD. Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma. Int J Radiat Oncol Biol Phys 81(1):167-174, 9/2011. e-Pub 7/2010. PMID: 20643518.
59. Mazloom A, Rodriguez A, Ha CS, Medeiros LJ, Wogan C, Shihadeh F, Allen P, Fowler N, Dabaja B. Incidence of gastric involvement in patients with nongastrointestinal extranodal marginal zone lymphoma. Cancer 117(11):2461-6, 6/2011. e-Pub 12/2010. PMID: 24048794.
60. Dabaja BS, Rebueno NC, Mazloom A, Thorne S, Perrin KJ, Tolani N, Das P, Delclos ME, Iyengar P, Reed VK, Horace P, Salehpour MR. Radiation for Hodgkin's lymphoma in young female patients: a new technique to avoid the breasts and decrease the dose to the heart. Int J Radiat Oncol Biol Phys 79(2):503-507, 2/2011. e-Pub 4/2010. PMID: 20418023.
61. Mazloom A, Rodriguez A, Ha CS, Medeiros LJ, Wogan C, Shihadeh F, Allen P, Fowler N, Dabaja B. Incidence of gastric involvement in patients with non-gastrointestinal extranodal marginal zone lymphoma. Cancer 117(11). e-Pub 12/2010. PMID: 21157949.
62. Zreik TG, Mazloom A, Chen Y, Vannucci M, Pinnix CC, Fulton S, Hadziahmetovic M, Asmar N, Munkarah AR, Ayoub CM, Shihadeh F, Berjawi G, Hannoun A, Zalloua P, Wogan C, Dabaja B. Fertility drugs and the risk of breast cancer: a meta-analysis and review. Breast Cancer Res Treat 124(1):13-26, 11/2010. e-Pub 8/2010. PMID: 20809361.
63. Phan J, Mazloom A, Medeiros LJ, Zreik TG, Wogan C, Shihadeh F, Rodriguez MA, Fayad L, Fowler N, Reed V, Horace P, Dabaja BS. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol 28(27):4170-4176, 9/2010. e-Pub 8/2010. PMID: 20713859.
64. Mazloom A, Medeiros LJ, McLaughlin PW, Reed V, Cabanillas FF, Fayad LE, Pro B, Gonzalez G, Iyengar P, Urbauer DL, Dabaja BS. Marginal zone lymphomas: factors that affect the final outcome. Cancer 116(18):4291-4298, 9/2010. PMID: 20549822.
65. Iyengar P, Mazloom A, Shihadeh F, Berjawi G, Dabaja B. Hodgkin lymphoma involving extranodal and nodal head and neck sites: characteristics and outcomes. Cancer 116(16):3825-3829, 8/2010. PMID: 20564093.
66. Mazloom A, Fowler N, Medeiros LJ, Iyengar P, Horace P, Dabaja BS. Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the MD Anderson Cancer Center experience. Leuk Lymphoma 51(7):1217-1224, 7/2010. PMID: 20443676.
67. Duvic M, Donato M, Dabaja B, Richmond H, Singh L, Wei W, Acholonu S, Khouri I, Champlin R, Hosing C. Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome. J Clin Oncol 28(14):2365-2372, 5/2010. e-Pub 3/2010. PMID: 20351328.
68. Dabaja B, Perrin KJ, Romaguera JE, Horace P, Wogan CF, Shihadeh F, Salehpour MR. Successful treatment of a free-moving abdominal mass with radiation therapy guided by cone-beam computed tomography: a case report. J Med Case Rep 4:329, 2010. e-Pub 10/2010. PMCID: PMC2974745.
69. Hoppe RT, Advani RH, Ambinder RF, Bierman PJ, Bloomfield CD, Blum K, Dabaja B, Djulbegovic B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hudson MM, Kaminski MS, Love G, Maloney DG, Mansur D, Mauch PM, Moore JO, Schilder RJ, Weiss LM, Winter JN, Yahalom J, Zelenetz AD,. Hodgkin disease/lymphoma. J Natl Compr Canc Netw 6(6):594-622, 7/2008. PMID: 18597713.
70. Ha CS, Kong JS, Dabaja BS, Fayad LE, Hess MA, Kim EE, Podoloff DA, Cabanillas F, Cox JD, Macapinlac HA. How often does 18f-FDG PET scan change management during treatment of Hodgkin lymphoma (HL)? International Journal of Radiation OncologyBiologyPhysics 69(3), 11/2007.
71. Geara FB, Nasr E, Tucker SL, Charafeddine M, Dabaja B, Eid T, Abbas J, Salem Z, Shamseddine A, Issa P, El Saghir N. Breast cancer patients with 10 or more involved axillary lymph nodes treated by multimodality therapy: influence of clinical presentation on outcome. Int J Radiat Oncol Biol Phys 68(2):364-369, 6/2007. e-Pub 2/2007. PMID: 17324529.
72. Dabaja B, Cox JD, Buchholz TA. Radiation therapy can still be used safely in combined modality approaches in patients with Hodgkin's lymphoma. J Clin Oncol 25(1):3-5, 1/2007. PMID: 17194900.
73. Dabaja B, Salehpour MR, Rosen I, Tung S, Morrison WH, Ang KK, Garden AS. Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: comparison of split-field and whole-field techniques. Int J Radiat Oncol Biol Phys 63(4):1000-1005, 11/2005. e-Pub 6/2005. PMID: 15978743.
74. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 101(3):518-526, 8/2004. PMID: 15274064.
75. Dabaja BS, McLaughlin P, Ha CS, Pro B, Meyers CA, Seabrooke LF, Wilder RB, Kyritsis AP, Preti HA, Yung WK, Levin V, Cabanillas F, Cox JD. Primary central nervous system lymphoma: phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy. Cancer 98(5):1021-1028, 9/2003. PMID: 12942571.
76. Dabaja BS, Ha CS, Wilder RB, Pro B, McLaughlin P, Cabanillas F, Cox JD. Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer J 9(4):321-324, Jul-Aug, 7/2003. PMID: 12967143.
77. Cox JD, Ha CS, Lee HK, Dabaja BS, Wilder RB. Uncertainties in contemporary treatment of aggressive lymphomas. Rays 28(3):289-292, Jul-Sep, 7/2003. PMID: 15018315.
78. Dabaja BS, Ha CS, Thomas DA, Wilder RB, Gopal R, Cortes J, Bueso-Ramos C, Hess MA, Cox JD, Kantarjian HM. The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma. Cancer 94(10):2738-2744, 5/2002. PMID: 12173345.
79. Dabaja BS, O'Brien SM, Kantarjian HM, Cortes JE, Thomas DA, Albitar M, Schlette ES, Faderl S, Sarris A, Keating MJ, Giles FJ. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome. Leuk Lymphoma 42(3):329-337, 7/2001. PMID: 11699397.
80. Taher A, Ammash Z, Dabaja B, Nasrallah A, Mourad FH. Ticlopidine-induced aplastic anemia and quick recovery with G-CSF: case report and literature review. Am J Hematol 63(2):90-93, 2/2000. PMID: 10629575.
81. Shamseddine AI, Taher A, Dabaja B, Dandashi A, Salem Z, El Saghir NS. Combination cisplatin-vinorelbine for relapsed and chemotherapy-pretreated metastatic breast cancer. Am J Clin Oncol 22(3):298-302, 6/1999. PMID: 10362341.
82. Dabaja BS, Faderl S, Thomas D, Cortes J, O'Brien S, Nasr F, Pierce S, Hayes K, Glassman A, Keating M, Kantarjian HM. Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications. Leukemia 13(6):869-872, 6/1999. PMID: 10360374.
83. Taher A, Shamsseddine A, Saghir N, Seoud M, Mourad F, Dabaja B, Khalil A. Acquired protein C deficiency following cisplatinum-navelbine administration for locally advanced breast cancer. Case report. Eur J Gynaecol Oncol 20(4):323-324, 1999. PMID: 10475134.
84. Jurjus AR, Abou-Nasr T, Dabaja B. Pattern of growth of Lebanese preschool children. Lebanese University Thesis 2(2):1-27, 7/1991.
85. Jain P, Sargent R, Castle KO, Benjamini O, Konoplev S, Dabaja BS, Kadia T. Multiple recurrent extra-medullary relapses of high grade diffuse large B cell lymphoma presenting in leukemic phase. J Clin Oncol. Submitted.

Invited Articles

1. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Tsien C, Winter JN, Yahalom J, Burns JL, Sundar H. Hodgkin lymphoma, version 2.2015. J Natl Compr Canc Netw 13(5):554-86, 5/2015. PMID: 25964641.

Editorials

1. Dabaja BS. In The Battle of Proton Versus Photon? The Patient Must Win. Int Journal of Radiation Oncology, Biology, Physics, 2015.
2. Dabaja B. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: A multi-institutional, matched cohort study. Breast Quarterly 23(2):134-135, 11/2012. e-Pub 11/2012.
3. Dabaja B. Comparison of three different mediastinal radiotherapy techniques in female patients: impact on heart sparing and dose of the breasts. Breast Diseases 19(3):264, 1/2008.

Abstracts

1. R Zhou, J Yang, T Pan, S Milgrom, C Pinnix, A Shi, Y Liu, Q Nguyen, D Gomez, Dabaja B, P Balter, L Court, Z Liao. SU-E-J-129: Atlas Development for Cardiac Automatic Contouring Using Multi-Atlas Segmentation. Medical Physics, 6/2015. PMID: 26127520.
2. Akhtari M, Reddy J, Pinnix C, Allen P, Osborne E, Gunther J, Milgrom S, Smith G, Wogan C, Fowler N, Rodriguez A, Dabaja B. Excellent Outcomes in Primary Cutaneous B-Cell Lymphoma after very Low Dose Radiation. ASTRO 57th Annual Meeting, 2015.
3. N/A. Extranodal Non-Hodgkin's Lymphoma: Clinical and Technical Advances in the Management of Primary Mediastinal lymphoma, gastric lymphoma, and Cutaneous. ASTRO 57th Annual Meeting, 2015.
4. Milgrom S, Nieto Y, Pinnix C, Smith G, Reed V, Kebriaei P, Dabaja B. Graft-Versus-Host Disease Following Radiation Therapy in Patients with a History of Allogeneic Stem Cell Transplant. ASTRO 57th Annual Meeting, 2015.
5. Pinnix C, Esmaeli B, Smith G, Milgrom S, Reed V, Arzu I, Shank J, Horace P, Allen K, Turner S, Morrell G, Fowler N, Dabaja B. Low dose 4 Gy Orbital Radiation for Therapy of Indolent B-Cell Lymphoma of the Ocular Adnexa. ASTRO 57th Annual Meeting, 2015.
6. Pinnix C, Smith G, Milgrom S, Osborne E, Reddy J , Akhtari M, Reed V, Arzu I, Allen P, Wogan C, Fanale M, Oki Y, Turturro F, Romaguera J, Fayad L, Fowler N, Westin J, Nastoupil L, Hagemeister F, Rodriguez A, Ahmed S, Nieto Y, Dabaja B. Predictors of Radiation Pneumonitis in Patients Receiving Intensity Modulated Radiation Therapy for Hodgkin and Non Hodgkin Lymphoma. ASTRO 57th Annual Meeting, 2015.
7. Pinnix C, Dabaja B, Milgrom S, Smith G, Reed V, Arzu I, Westin J, Rondon G, Hosing C, Nieto Y, Ahmed S. Salvage Therapy Prior to Stem Cell Transplantation for Chemorefractory B-Cell Lymphoma. ASTRO 57th Annual Meeting, 2015.
8. Maraldo MV, Dabaja BS, Headley J, Illidge T, Petersen PM, Schut DA, Tsang R, Specht L. Involved node radiotherapy planning for early stage Hodgkin lymphoma: experiences of the International Lymphoma Radiation Oncology Group. Proceedings of the American Society of Radiation Oncology Annual Meeting, 9/2014.
9. Hoppe RT, Harrison C, Tavallaee M, Bashey S, Li S, Million L, Dabaja B, Duvic M, Kim YH. Low dose (12 Gy) total skin electron beam therapy (TSEBT) for mycosis fungoides (MF): results of 3 phase II clinical trials. Proceedings of the American Society of Radiation Oncology Annual Meeting, 9/2014.
10. Pinnix CC, Westin J, Ahmed MA, Reed V, Romaguera JE, Oki Y, Rodriguez MA, Fayad L, Hagemeister FB, Kwak LW, Medeiros LJ, Turturro F, Davis RE, Dabaja B. The role of radiation therapy in the treatment of primary mediastinal B cell lymphoma treated with rituximab containing regimens. Proceedings of the American Society of Radiation Oncology Annual Meeting, 9/2014.
11. Xu-Monette ZY, Dabaja BS, Tzankov A, Visco C, Miranda R, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards K, His E, Choi WL, Van Krieken JHJM, Huh J, Ai WZ, Ponzoni M, Ferreri A, Moller MB, Zhao X, Go RS, Winter JN, Pris MA, McDonnell TJ, Li Y, Medeiros LJ, Young KH. Radiation therapy significantly improves survival of patients with diffuse large B-cell lymphoma associated with MYC translocation: a report from the International DLBCL Rituximab-chop Consortium Program. Proceedings American Society of Hematology Annual Meeting, 12/2013.
12. Walker GV, Shihadeh F, Kantarjian H, Gidley PW, Arzu I, Pinnix CC, Reed VK, Dabaja B. Controlling central nervous system leukemia: does the extent of the radiation therapy field influence outcomes?. Proceedings of the American Society of Radiation Oncology Annual Meeting, 9/2013.
13. Dabaja B, Wang H, Voong RK, Pinnix CC, Shihadeh F, Reed VK, Salehpour M, Arzu I, Garcia J. Image guided radiation therapy proves its benefit in detecting the daily unpredictable shape change of the stomach, a study of patients treated for stomach lymphoma. Proceedings of the American Society of Radiation Oncology Annual Meeting, 9/2013.
14. Dabaja B, Voong RK, McSpadden K, Pinnix CC, Shihadeh F, Reed VK, Salehpour M, Arzu I, Wang H, Garcia J. Intensity modulated radiation therapy (IMRT) using butterfly technique offers a dosimetric advantage to critical organs in young female patients with mediastinal Hodgkin’s lymphoma. Proceedings of the American Society of Radiation Oncology Annual Meeting, 9/2013.
15. Dabaja B, Voong R, Shihadeh F, Arzu I, Pinnix CC, Mazloom A, Medeiros L, Romaguera J, Rodriguez M, Allen P. Radiation therapy is a very effective modality in the treatment of mantle cell lymphoma, > 80% complete disppearance of disease site in heavily pretreated patients. Proceedings of the American Society of Radiation Oncology Annual Meeting, 9/2013.
16. L Court, J Yang, D Fullen, N Han, J Ko, S Mason, K Nguyen, S Stein, X Fave, M Hsieh, S Kuruvila, E Hillebrandt, J Palmer, B Beadle, Dabaja B, H Skinner, G Ibbott, P Balter. Patients Could (and Should) Be Treated in An Upright Position. Medical Physics, 6/2013.
17. Dabaja B, Liang F, Shihadeh F, Etzel C, Medeiros L, Fayad L, Oki Y, Hagemeister F, Rodriguez A. Mid-therapy PET scan significantly predict outcome in patients with diffuse large B-cell lymphoma (DLBCL) treated with chemotherapy alone but not when consolidation radiation is added. Proceedings of the Annual Meeting of the American Society of Therapeutic Radiation Oncology, 2012.
18. Gardner K, Dabaja B, Reed V, Kim M, Gombos D, Sorensen E, Fowler N. Primary intraocular diffuse large B-cell lymphoma: outcomes following combined modality treatment. Proceedings of the Annual Pan Pacific Lymphoma Conference, 2012.
19. Dabaja B, Phan J, Medeiros LJ, Hagemeister FB, Chuang H, Fayad LE, Shihadeh F, Allen PK, Wogan C, Rodriguez A. Clinical implications of PET-negative residual disease at the completion of chemotherapy for diffuse large B-cell lymphoma. Proceedings of the 47th Annual Meeting of the American Society of Clinical Oncology, 2011.
20. Dabaja B, Shihadeh F, Etzel C, Fu-Wen L, Ballas L, Shirvani S, Rodriguez A, Fanale M, Younes A. Continuous decline in second malignancies in patients with Hodgkin lymphoma over the past 5 decades. Proceedings of the 53rd Annual Meeting of the American Society of Hematology, 2011.
21. Harrison C, Navi D, Lingala B, Armstrong R, Weng W, Sundram U, Dabaja B, Singh L, Duvic M, Hoppe RT, Kim YH. Efficient and reliable skin responses with unconventional low-dose total skin electron beam therapy (TSEBT) in mycosis fungoides (MF): a phase II study. Proceedings of the Annual Meeting of the Society of Investigative Dermatology, 2011.
22. Ballas LK, Fanale MA, Younes A, Milbourne A, Shervani SM, Shihadeh F, Dabaja BS. Hodgkin lymphoma and pregnancy: outcomes based on modern chemotherapy and radiotherapy. Proceedings of the 47th Annual Meeting of the American Society of Clinical Oncology, 2011.
23. Allen P, Dabaja BS, Shihadeh FDA, Nickerson P, Ballas LK. Hodgkin's lymphoma: the use of modern combined modality therapy has significantly decreased the risk of second malignancies: the MD Anderson experience over five decades. Proceedings of the 47th Annual Meeting of the American Society of Clinical Oncology, 2011.
24. Hosing C, Saliba RM, Singh L, Popat U, Qazilash M, Anderlini P, Nieto Y, Alousi A, Frazier E, Dabaja B, Champlin RE, Duvic M. Total skin electron beam radiation therapy and allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sézary syndrome. Proceedings of the 53rd Annual Meeting of the American Society of Hematology, 2011.
25. Batty N, Hagemeister FB, Romaguera JE, Rodriguez MA, McLaughlin P, Samaniego F, Copeland A, Dabaja BS, Younes A. ABVD chemotherapy with interferon for advanced stage classical Hodgkin’s lymphoma: A ten-year follow-up study. Proceedings of the 46th Annual Meeting of the American Society of Clinical Oncology, 2010.
26. Shihadeh F, Reed V, Mazloom A, Phan J, Kantarjian H, DeLima M, Dabaja B. Central nervous system disease and acute myeloid leukemia or chronic myeloid leukemia: outcome and prognostic factors. Proceedings of the 46th Annual Meeting of the American Society of Clinical Oncology, 2010.
27. Reed V, Shah J, Mazloom A, Weber D, Phan J, Orlowski B, Thomas S, Wang M, Alexanian R, Dabaja B. Outcome and prognostic factors in solitary plasmacytoma. Proceedings of the 46th Annual Meeting of the American Society of Clinical Oncology, 2010.
28. Phan J, Mazloom A, Abboud M, Reed V, Dabaja B. Supradiaphragmatic consolidative radiation therapy in the management of stage III Hodgkin’s disease treated with ABVD-based chemotherapy. Proceedings of the 92nd Annual Meeting of the American Radium Society, 2010.
29. Phan J, Mazloom A, Medeiros LJ, Shihadeh F, Rodriguez A, Fayad L, Fowler N, Reed V, Horace P, Dabaja B. The benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with RCHOP chemotherapy. Proceedings of the 92nd Annual Meeting of the American Radium Society, 2010.
30. Ballas LK, Pan I, Guadagnolo BA, Smith BD, Buchholz TA, Dabaja BS. Trends in utilization of intensity-modulated radiotherapy in diffuse large B-cell lymphoma in the U.S. from 2001 to 2005: a population-based study. Proceedings of the Annual Meeting of the American Society of Radiation Oncology, 2010.
31. Hosing C, Dabaja B, Saliba R, Acholonu S, Khouri IF, Pro B, Popat U, Qazilbash M, Champlin R, Duvic M. Allogeneic hematopoietic stem cell transplantation in patients with advanced mycosis fungoides and Sézary syndrome. Proceedings of the 51st Annual Meeting of the American Society of Hematology, 2009.
32. Phan J, Mazloom A, Shihadeh F, Rodriguez A, Fayad L, Fowler N, Dabaja B. Outcome of patients with diffuse large B-cell lymphoma is directly related to type of chemotherapy and the use of radiation. Proceedings of the Annual Meeting of the American Society of Therapeutic Radiation Oncology (#1182), 2009.
33. Mazloom A, Fowler N, Iyengar P, Reed V, Dabaja B. Primary testicular diffuse large B-cell lymphoma: the MD Anderson Cancer Center Experience. Proceedings of the 51st Annual Meeting of the American Society of Hematology, 2009.
34. Phan J, Mazloom A, Abboud M, Reed V, Dabaja B. Supradiaphragmatic consolidative radiation therapy in the management of stage III Hodgkin’s disease treated with ABVD-based chemotherapy. Proceedings of the 51st Annual Meeting of the American Society of Hematology, 2009.
35. Zreik T, Munkarahn A, Gonzalez N, Munsell M, Berjawi G, Asmar N, Dabaja B. Fertility drugs and risk of breast cancer: a meta-analysis. Proceedings of the 39th Annual Meeting of the Society of Gynecologic Oncology, 2008.
36. Dabaja B, Rebueno N, Thorne S, Tolani N, Das P, Younes A, Fanale M, Delclos M, Iyengar P, Reed V, Salehpour MR. Hodgkin’s lymphoma in young female patients can be safely treated with radiation. Proceedings of the Annual Meeting of the American Society of Therapeutic Radiation Oncology, 2008.
37. Mazloom A, Reed V, Pro B, Fayad, L, Urbauer D, McLaughlin P, Dabaja B. Marginal zone lymphoma: factors that affect the final outcome, a study of 275 patients. Proceedings of the 50th Annual Meeting of the American Society of Hematology, 2008.
38. Ha CA, Kong JS, Dabaja BS, Fayad LE, Hess MA, Kim EE, Podoloff DA, Cabanillas F, Cox JD, Macapinlac HA. How often does 18f-FDG PET scan change management during treatment of Hodgkin lymphoma (HL)?. Proceedings of the American Society of Radiation Oncology Annual Meeting, 1/2007.
39. Fanale MA, Fayad LE, Romaguera JE, McLauglin PW, Hagemeister FB, Pro B, Dabaja BS, Medeiros LJ, Gilliam M, Wedgwood AR, Younes A. Experience with R-CHOP in patients with lymphocyte predominant Hodgkin lymphoma (LPHL). Proceedings of the German Hodgkin's Lymphoma Conference, 2007.
40. Iyengar P, Dabaja B. Hodgkin's lymphoma of the head and neck: 30 years experience. Proceedings of the 89th Annual Meeting of the American Radium Society, 2007.
41. Dabaja B, Nasr FL, Chahine GY, Moukaddem WT, Farhat FS, Tueini EA, Kattan JG, Dagher JE, Younes FC, Ghosn MG. Estramustine, zoledronic acid and weekly docetaxel in metastatic androgen independent prostate cancer (MAIPC). Proceedings of the 40th Annual Meeting of the American Society of Clinical Oncology, 2004.
42. Dabaja BS, Salehpour M, Rosen I, Morrison WH, Tung S, Ang KK, Garden A. Intensity modulated radiation therapy (IMRT) of head and neck cancers, comparison of half beam and whole field techniques. Proceedings of the World Congress on Medical Physics and Biomedical Engineering, 2003.
43. Dabaja BS, Ha, Pro B, Cabanillas F, Cox JD. Non-gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma: the treatment outcomes and patterns of failure. Proceedings of the 39th Annual Meeting of the American Society of Clinical Oncology, 2003.
44. Dabaja B, McLaughlin P, Myers C, Wilder R, Kryistis A, Yung W, Levin V, Cabanillas F, Cox JD, Ha C. Phase I evaluation of infusional BUdR with accelerated fractionation radiation therapy following idarubicin, dexamethasone, cytosine arabinoside (Ara-C), cisplatin, and high dose methotrexate (HD-MTX) for the treatment of primary CNS lymphoma. Proceedings of the 89th Annual Meeting of the Radiological Society of North America, 2002.
45. Dabaja BS, Ajani J, Pro B, AbiSaid D, Nasr F, Campos L. Small bowel adenocarcinoma: presentations, prognostic factors, and clinical outcome. Proceedings of the 38th Annual Meeting of the American Society of Clinical Oncology, 2002.
46. Dabaja BS, Ha, Wilder R, Pro B, McLaughlin P, Cabinillas F, Cox JD. The importance of esophagogastroduodenscopy (EDG) in evaluation of non-gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma. Proceedings of the 8th International Conference on Malignant Lymphoma, 2002.
47. Dabaja BS, Kantarjian HM, Cortes JE, Thomas DA, Sarris A, O'Brien SM, Keating MJ, Giles FJ. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, dexamethasone (hyperCVAD) regimen in Richter's syndrome. Proceedings of the 37th Annual Meeting of the American Society of Clinical Oncology, 2001.
48. Dabaja BS, Ha C, Thomas D, Gopal R, Cortes J, Ramos CB, Hess M, Cox JD, Kantarjian H. The role of radiation therapy for mediastinal disease in adult T-cell lymphoblastic lymphoma. Proceedings of the 42nd Annual Meeting of the American Society of Hematology, 2000.
49. Dabaja BS, Estallila OF, Giles FJ, O'Brien SM, Keating MJ, Sarris AH, Mederios LJ, Cabanillas F. A distinct subtype of blastoid NK cells non-Hodgkin's lymphoma (NHL) expressing TdT: clinicopathologic analysis of 4 cases. Proceedings of the 41st Annual Meeting of the American Society of Hematology, 1999.
50. Pro B, Ajani J, Dabaja B, Hargraves K, Fairweather J. A phase I study of taxol carboplatin and FT plus leucovorin in patients with advanced upper gastrointestinal carcinomas. Proceedings of the 39th Annual Meeting of the American Society of Clinical Oncology, 1999.
51. Dabaja BS, Kanrarjian HM, Cortes JE, Thomas DA, Sarris A, O'Brien SM, Keating MJ, Giles FJ. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, dexamethasone (hyperCVAD) regimen in Richter's syndrome. Proceedings of the 41st Annual Meeting of the American Society of Hematology, 1999.
52. Dabaja B, Ajani J, Pro B, AbiSaid D, Nasr F, Campos L. Small bowel adenocarcinoma: 20 years experience at UT MD Anderson Cancer Center. Proceedings of the 35th Annual Meeting of the American Society of Clinical Oncology, 1999.
53. Dabaja B, Cortes J, Whimbey E, Nasr F, Kantarjian H, Estey E. Relationship between CMV antigenemia and death in non-transplanted patients with leukemia. Proceedings of the 40th Annual Meeting of the American Society of Hematology, 1998.
54. Dabaja BS, Faderl S, Thomas D, Cortes J, O'Brien S, Nasr F, Pierce S, Hayes K, Glassman A, Keating M, Kantarjian HM. Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic: incidence, associations and implications. Proceedings of the 39th Annual Meeting of the American Society of Hematology, 1997.
55. Dabaja B, Kantarjian H, Pierce S, Keating M, Estey E. The outcome of FUO during induction therapy of AML/MDS. Proceedings of the 39th Annual Meeting of the American Society of Hematology, 1997.
56. Dabaja BS, Shamseddine AI, Salem ZMK, Nasr TA, Taher AT, El Saghir N, Dandashi AH. Treatment of metastatic breast cancer with vinorelbine (VNB) and cisplatinum (DDP): a clinical phase II trial. Proceedings of the 5th International Congress on Anti-Cancer Chemotherapy, 1995.
57. Bashey S, Tavallaee M, Duvic M, Dabaja B, Talpur R, Wilson L, Foss F, Girardi M, Li S, Rozati S, Million L, Hoppe R, Kim YH. A multicenter, open-label, randomized, phase I/II study evaluating the safety and efficacy of low-dose (12 Gy) total skin electron beam therapy (TSEBT) combined with vorinostat versus low-dose TSEBT monotherapy in patients with mycosis fungoides. 74th Annual Society for Investigative Dermatology Meeting. Submitted.
58. Lee ST, Teegavarupu P, Karri A, Anireddy S, Hagemeister F, Romaguera J, Fayad L, Rodriguez M, Samaniego F, Fowler N, Oki Y, Turturro F, Westin J, Kwak LW, Dabaja B, Feng L, Davis RE, Neelapu SS. Antibiotic therapy of H. pylori negative gastric MALT lymphoma. Proceedings of the 40th Annual Meeting of the American Society of Hematology. Submitted.
59. Weber Donna, Shah Jatin, Horowitz Sandra B, Dabaja Bouthaina Shbib, Pinnix Chelsea Camille, Thomas Sheeba K, Orlowski Robert Manasanch, Elisabet Esteve, Qazilbash, Muzaffar H, Shah Nina, Mullen Ellen C, Atmar Jill S, Wang Michael, Milgrom Sarah A, Feng Lei, Sevin Adrienne, Reed Valerie Klairisa, YU JUN, LeeHans Chulhee. Clinical characteristics, outcomes and predictors of progression to multiple myeloma (MM) in 61 patients with solitary plasmacytoma. Proceedings of the 15th International Myeloma Workshop. Submitted.
60. Nieto Y, Popat U, Anderlini P, Hosing C, Andersson BS, Valdez B, Shpall EJ, Ahmed S, Qazilbash M, Kebriaei P, Alousi A, Bassett R, Oki Y, Fanale M, Hagemeister F, Dabaja BS, Reed V, Pinnix C, Tewari P, Worth L, Champlin R, Jones RB. Phase 2 trial of high-dose gemcitabine, busulfan and melphalan with autologous stem cell transplant (ASCT) for patients with refractory Hodgkin's lymphoma (HL). 40th Annual Meeting of the European Society for Blood and Marrow Transplantation. Submitted.

Book Chapters

1. Younes A, Carbone A, Dabaja B, Johnson P, Ansell S, Kuruvilla J. Hodgkin’s lymphoma. In: De Vita's Principle and Practice of Oncology, 10th. Lippincott Williams & Wilkins: Philadelphia, 1526-51, 2015. ISBN: 978-1451192940.
2. Smith GL, Wilson LD, Dabaja B. Mycosis fungoides. In: Clinical Radiation Oncology, 4. Gunderson & Tepper, 2015. ISBN: 978-0323240987.
3. Dabaja B, Younes A, Coiffier. Cutaneous B cell lymphomas. In: Lymphoma: Diagnosis and Treatment. Current clinical oncology, 43. Ed(s) A Younes, B Coiffier. Humana Press/ Springer: Florissant, MO, 2013. ISBN: 9781627034074.
4. Dabaja B. Diffuse large B-cell lymphoma : nodal and extranodal including primary mediastinal lymphoma. In: Hematologic Malignancies. Radiation medicine rounds, 3, 3. Ed(s) MB Tomblyn, K Winkfield, Dabaja B. Demos Medical Publishing: New York, 2012. ISBN: 9781936287772.
5. Pinnix CC, Dabaja B. Leukemia including lymphoblasticlymphoma. In: Hematologic Malignancies. Radiation medicine rounds, 3, 9. Ed(s) MB Tomblyn, K Winkfield, Dabaja B. Demos Medical Publishing: New York, 2012. ISBN: 9781936287772.
6. Fanale M, Dabaja B, Anderolini P, Popat UR. Lymphoma: hodgkin lymphoma. In: 60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center. Ed(s) A Rodriguez, A Walters, T Burke. Springer Science and Business Media: New York, 2012. ISBN: 9781461451969.
7. Pinnix CC, Dabaja B. Marginal zone lymphoma. In: Hematologic Malignancies. Radiation medicine rounds, 3, 3. Ed(s) MB Tomblyn, K Winkfield, Dabaja B. Demos Medical Publishing: New York, 2012. ISBN: 9781936287772.
8. Dabaja B. Mycosis fungoides, presentation, diagnosis, and treatment strategy. In: Hematologic Malignancies. Radiation medicine rounds, 3, 3. Ed(s) MB Tomblyn, K Winkfield, Dabaja B. Demos Medical Publishing: New York, 2012. ISBN: 9781936287772.
9. Fayad LE, Konoplev S, Chuang HH, Rodriguez MA, commentary by Dabaja BS. Aggressive and highly aggressive B cell lymphomas. In: The MD Anderson Manual of Medical Oncology, 2nd. Ed(s) Kantarjian J, Wolff RA, Koller CA. McGraw-Hill Medical: New York, 147-182, 2011.
10. Dabaja B, Ha CS, Cox JD. Leukemia and lymphoma. In: Radiation Oncology, 9th. Ed(s) Cox JD, Ang KK. Elsevier: Philadelphia, 875-911, 2009.
11. Dabaja B, Ha C. Leukemias and plasma cell disorders. In: Handbook of Radiation Oncology: Basic Principles and Clinical Protocols. Ed(s) Haffty BG, Wilson LG. Jones and Barlett Publishers: Sudbury, MA, 739-754, e-Book 2009.

Books (edited and written)

1. Tomblyn M, Winkfield K, Dabaja B. Hematologic Malignancies. In: Radiation Medicine Rounds. 3, 3. Demos Medical Publishing: New York, 2012. ISBN: 9781936287772.
2. Bouthaina Dabaja and Andrea Ng. Challenging cases in Lymphoma. Springer. Submitted.

Last updated: 5/13/2016